GlycoLog
Blackstone Labs GlycoLog is an 'Other Combinations' supplement with 7 ingredients, often used for metabolic and glucose support. It provides Chromium at a clinically studied dose of 300mcg, alongside Gymnema Extract (1000mg) and Bitter Melon (500mg). The product offers transparent labeling, detailing all components and their quantities. It has an N+ Score of 69, earning a C- grade, indicating an average quality assessment. This supplement may be considered by individuals interested in specific ingredients that research suggests may support glucose metabolism.
About This Product
GlycoLog by Blackstone Labs is a vitamins & minerals supplement containing 7 active ingredients. It has earned an N+ Score of 69/100 (Grade C-).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include Chromium.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +1 ingredient(s) at clinical dose levels
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (7 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Chromium | 300.000 mcg | Optimal |
| Bioperine | 5.000 mg | N/A |
| Gymnema extract | 1000.000 mg | N/A |
| Cinnamon extract | 250.000 mg | N/A |
| Bitter Melon | 500.000 mg | N/A |
| Super Berberine | 300.000 mg | N/A |
| Sodium R-Lipoate | 150.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.
